Monovalent Rotavirus Vaccine Effectiveness Against Rotavirus Hospitalizations Among Children in Zimbabwe | Zendy

Hilda Mujuru | Zendy; Eleanor Burnett | Zendy; Kusum Nathoo | Zendy; Ismail Ticklay | Zendy; Nhamo A Gonah | Zendy; Arnold Mukaratirwa | Zendy; Chipo Berejena | Zendy; Portia Manangazira | Zendy; Maxwell Rupfutse | Zendy; Goitom Weldegebriel | Zendy; Jason M. Mwenda | Zendy; Catherine Yen | Zendy; Umesh D. Parashar | Zendy; Jacqueline E. Tate | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Monovalent Rotavirus Vaccine Effectiveness Against Rotavirus Hospitalizations Among Children in Zimbabwe

Author(s) -

Hilda Mujuru,

Eleanor Burnett,

Kusum Nathoo,

Ismail Ticklay,

Nhamo A Gonah,

Arnold Mukaratirwa,

Chipo Berejena,

Portia Manangazira,

Maxwell Rupfutse,

Goitom Weldegebriel,

Jason M. Mwenda,

Catherine Yen,

Umesh D. Parashar,

Jacqueline E. Tate

Publication year - 2018

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciy1096

Subject(s) - medicine , rotavirus , rotavirus vaccine , rotavirus infections , pediatrics , virology , reoviridae , rotavirus gastroenteritis , environmental health , virus

Rotavirus is a leading cause of mortality among children <5 years old. We evaluated monovalent rotavirus vaccine effectiveness (VE) under conditions of routine use at 2 surveillance sites in Harare, Zimbabwe, after vaccine introduction in May 2014.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research